Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Observational Retrospective Study to Assess the Use of Ribociclib in Patients With HR+, HER2- Metastatic Breast Cancer Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
CARE Initiative: Real-world Emulation of the PALOMA-2 Trial
- Status
- COMPLETED
- Phase
- N/A
A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
- Status
- RECRUITING
- Phase
- N/A
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)
- Status
- COMPLETED
- Phase
- N/A
Collaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
The COMPASSION Study
- Status
- RECRUITING
- Phase
- NA
STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)
- Status
- RECRUITING
- Phase
- NA
Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
- Status
- RECRUITING
- Phase
- PHASE2
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.
- Status
- RECRUITING
- Phase
- N/A